These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11748773)

  • 1. Alzheimer's disease in the UK: comparative evidence on cost of illness and volume of health services research funding.
    Lowin A; Knapp M; McCrone P
    Int J Geriatr Psychiatry; 2001 Dec; 16(12):1143-8. PubMed ID: 11748773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
    Green C; Picot J; Loveman E; Takeda A; Kirby J; Clegg A
    Pharmacoeconomics; 2005; 23(12):1271-82. PubMed ID: 16336020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
    Luengo-Fernandez R; Leal J; Gray AM
    Eur J Neurol; 2012 Jan; 19(1):149-54. PubMed ID: 21951976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: the burden of the illness in England.
    Gray A; Fenn P
    Health Trends; 1993; 25(1):31-7. PubMed ID: 10171428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of coronary heart disease in the UK.
    Liu JL; Maniadakis N; Gray A; Rayner M
    Heart; 2002 Dec; 88(6):597-603. PubMed ID: 12433888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual cost of bipolar disorder to UK society.
    Das Gupta R; Guest JF
    Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.
    Luengo-Fernandez R; Leal J; Gray A
    BMJ Open; 2015 Apr; 5(4):e006648. PubMed ID: 25869683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of Alzheimer's disease in the United Kingdom. Cost of care and disease severity for non-institutionalised patients with Alzheimer's disease.
    Souêtre E; Thwaites RM; Yeardley HL
    Br J Psychiatry; 1999 Jan; 174():51-5. PubMed ID: 10211151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial.
    Patel A; Knapp M; Perez I; Evans A; Kalra L
    Stroke; 2004 Jan; 35(1):196-203. PubMed ID: 14684783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high cost of not funding stroke research: a comparison with heart disease and cancer.
    Rothwell PM
    Lancet; 2001 May; 357(9268):1612-6. PubMed ID: 11377668
    [No Abstract]   [Full Text] [Related]  

  • 12. The annual societal cost of alcohol misuse in Scotland.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2002; 20(13):891-907. PubMed ID: 12381241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial.
    Rivero-Arias O; Campbell H; Gray A; Fairbank J; Frost H; Wilson-MacDonald J
    BMJ; 2005 May; 330(7502):1239. PubMed ID: 15911536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2016 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2016 Apr; 12(4):459-509. PubMed ID: 27570871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial.
    Jones J; Wilson A; Parker H; Wynn A; Jagger C; Spiers N; Parker G
    BMJ; 1999 Dec; 319(7224):1547-50. PubMed ID: 10591720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training care givers of stroke patients: economic evaluation.
    Patel A; Knapp M; Evans A; Perez I; Kalra L
    BMJ; 2004 May; 328(7448):1102. PubMed ID: 15130978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted economic damage from a quick, simple Alzheimer's disease cure.
    Norins LC
    Med Hypotheses; 2019 Dec; 133():109398. PubMed ID: 31539811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Jia J; Wei C; Chen S; Li F; Tang Y; Qin W; Zhao L; Jin H; Xu H; Wang F; Zhou A; Zuo X; Wu L; Han Y; Han Y; Huang L; Wang Q; Li D; Chu C; Shi L; Gong M; Du Y; Zhang J; Zhang J; Zhou C; Lv J; Lv Y; Xie H; Ji Y; Li F; Yu E; Luo B; Wang Y; Yang S; Qu Q; Guo Q; Liang F; Zhang J; Tan L; Shen L; Zhang K; Zhang J; Peng D; Tang M; Lv P; Fang B; Chu L; Jia L; Gauthier S
    Alzheimers Dement; 2018 Apr; 14(4):483-491. PubMed ID: 29433981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The US economic and social costs of Alzheimer's disease revisited.
    Ernst RL; Hay JW
    Am J Public Health; 1994 Aug; 84(8):1261-4. PubMed ID: 8059882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic costs of Alzheimer's disease.
    Hay JW; Ernst RL
    Am J Public Health; 1987 Sep; 77(9):1169-75. PubMed ID: 3113273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.